Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia

Leukemia

Volumn 12, Issue 5, 1998, Pages 666-674

  Schenk, T M ^a,b   Keyhani, A ^a   Bottcher, S ^a   Kliche, K O ^a   Goodacre, A ^a   Guo, J Q ^a   Arlinghaus, R B ^a   Kantarjian, H M ^a   Andreeff, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute lymphocytic leukemia; BCR ABL; Hematopoietic progenitors; Lineage

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BCR ABL PROTEIN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPHORIN A; MICROSOMAL AMINOPEPTIDASE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOBLAST; LYMPHOCYTE TRANSFORMATION; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; T LYMPHOCYTE;

EID: 0031946415     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400986     Document Type: Article

References (24)

1. Dow LW, Martin P, Moohr J, Greenberg M, Macdougall LG, Najfeld V, Fialkow PJ. Evidence for clonal development of childhood acute lymphoblastic leukemia. Blood 1985; 66: 902-907.
2. Anastasi J, Feng J, Dickstein JI, Le Beau MM, Rubin MM, Larson RA, Rowley JD, Vardiman JW. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast phase vs Ph+ acute lymphoblastic leukemia. Leukemia 1996; 10: 795-802.
3. Abe R, Ishibashi T, Kimura H, Uchida T, Kariyone S. The significance of cytogenetic findings of erythroid colonies derived from a Ph+ ALL patient: fundamental differences between Ph+ ALL and blastic phase CML. Cancer Genet Cytogenet 1985; 18: 49-54.
4. Martin PJ, Najfeld V, Hansen JA, Penfold GK, Jacobson RJ, Fialkow PJ. Involvement of the B-lymphoid system in chronic myelogenous leukemia. Nature 1980; 278: 49-50.
5. Raskind WH, Fialkow PJ. The use of cell markers in the study of human hematopoietic neoplasia. Adv Cancer Res 1987; 49: 127-167.
6. Preti AH, O'Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM. Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients. Am J Med 1994; 97: 60-65.
7. Maurer J, Janssen JWG, Thiel E, Van Denderen J, Ludwig WD, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukemia by the polymerase chain reaction. Lancet 1991; 337: 1055-1058.
8. Melo JV, Myint H, Galton DAG, Goldman JM. P190 BCR-ABL chronic myeloid leukemia: the missing link with chronic myelomonocytic leukaemia? Leukemia 1994; 8: 208-211,
9. Melo JV. The molecular biology of chronic myeloid leukaemia. Leukemia 1996; 10: 751-756.
10. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R. Significance of the p210 vs p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411-2418.
11. Seeker-Walker LM, Craig JM. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review. Leukemia 1993; 7: 147-151.
12. Tachibana N, Raimondi SC, Lauer SJ, Sartain P, Dow LW. Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 1458-1461.
13. Dow LW, Tachibana N, Raimondi SC, Lauer SJ, Witte ON, Clark SS. Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q11 variants. Blood 1989; 73: 1291-1297.
14. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Hombe M, Redner A, Gray J, Pinkel D. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 1990; 250: 559-562.
15. Kornblau SM, Thall P, Huh YO, Estey E, Andreeff M. Analysis of CD7 expression in acute myelogenous leukemia: Martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance. Leukemia 1995; 9: 1735-1741.
16. Chas A, Grand F, Goldman JM, Gordon M. Parameters affecting the interpretation of BCR/ABL fluorescent in situ hybridization. Br J Haematol 1996; 93: 327 (Abstr.).
17. Kantarjian H, O'Brien S, Beran M, Keating M, Koller C, Robertson L, Andreeff M, Murphy S, Freireich E. Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia (ALL). Blood 1995; 86: 680 (Abstr.).
18. Kalousek DK, Dubé ID, Eaves CJ, Eaves AC. Cytogenetic studies of haemopoietic colonies from patients with an initial diagnosis of acute lymphoblastic leukaemia. Br J Haematol 1988; 70: 5-11.
19. Seeker-Walker LM, Cooke HMG, Browett PJ, Shippey CA, Norton JD, Coustan-Smith E, Hoffbrand AV. Variable Philadelphia breakpoints and potential lineage restriction of bcr rearrangement in acute lymphoblastic leukemia. Blood 1988; 72: 784-791.
20. Catovsky D. Ph1-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases? Br J Haematol 1979; 42: 493-498.
21. Gale RP, Butturini A. Ph-chromosome acute leukemias and acute phase CML: one or two diseases? Two. Leukemia Res 1990; 14: 295-297.
22. Berger R. Differences between blastic chronic myeloid leukemia and Ph+ acute leukemia. Leuk Lymphoma 1993; 11 (Suppl. 1): 235-237.
23. Craig JM, Hawkins JM, Yameda T, Ganeshaguru K, Metha AB, Seeker-Walker LM. First intron and M-bcr breakpoints are restricted to the lymphoid lineage in Philadelphia positive acute leukemia. Leukemia 1990; 4: 678-681.
24. Kitano K, Sato Y, Suda T, Miura Y. Difference of cell lineage expression of haemopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukemia. Br J Haematol 1990; 70: 21-26.